KP Tissue Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	3.89	2.43	-4.94	-10.25	1.24	-1.95
Loss (Gain) From Sale of Investments	0.66	0.5	0.13	4.46	5	-0.63
Loss (Gain) on Equity Investments	-4.61	-2.99	0.7	8.09	-6.13	1.43
Other Operating Activities	-0.01	0.65	3.82	-2.22	-0.35	1.01
Change in Accounts Receivable	-	-	-	-	0.02	0.15
Change in Accounts Payable	0.07	-0.6	0.29	-0.08	0.21	-
Investment in Securities	-	-	-	6.62	5.56	5.6
Other Investing Activities	6.96	6.97	6.98	-	-	-
Investing Cash Flow	6.96	6.97	6.98	6.62	5.56	5.6
Common Dividends Paid	-6.96	-6.97	-6.98	-6.62	-5.56	-5.6
Financing Cash Flow	-6.96	-6.97	-6.98	-6.62	-5.56	-5.6
Cash Income Tax Paid	0.07	-0.6	0.29	-0.08	2.28	1.02
Change in Working Capital	0.07	-0.6	0.29	-0.08	0.23	0.15

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.